Ming Zhu

Ming Zhu is a Partner at Braidwell in Stamford, CT, where she leverages deep expertise in biostatistics and healthcare investing to guide strategic investment decisions in the life sciences sector. At Braidwell, she focuses on deploying capital across a range of healthcare assets, specializing in clinical trial analysis, biotech investments, and supporting innovative health solutions through both public and private market strategies.

Prior to joining Braidwell in 2022, Ming Zhu served as a Consultant at Passage Bio and as Vice President at Deerfield Management, further strengthening her leadership in healthcare finance and investment. Her background in both consulting and asset management has shaped her data-driven approach to evaluating clinical-stage companies and high-impact medical technologies.

Ming Zhu holds a PhD in Biostatistics from Emory University, a Master of Science in Statistics from National University of Singapore, and a Bachelor of Statistics from the Special Class for the Gifted Young at University of Science and Technology of China. She is recognized for her expertise in statistics, data analysis, and clinical development, contributing significantly to the advancement of investment analytics and healthcare capital deployment in the investment industry.